Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Recruiting

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma SurvivorsFeasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Sponsor:

St. Jude Children's Research Hospital

Code:

NCT06480526

Conditions

High-risk Neuroblastoma

Eligibility Criteria

Sex: All

Age: 5+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by St. Jude Children's Research Hospital on 2025-03-25.